4.6 Article

Assessment of cardiometabolic risk factors in a national primary care electronic health record database

期刊

VALUE IN HEALTH
卷 10, 期 -, 页码 S29-S36

出版社

ELSEVIER SCIENCE INC
DOI: 10.1111/j.1524-4733.2006.00152.x

关键词

cardiometabolic risk; electronic health records; metabolic syndrome; prevalence; primary care

向作者/读者索取更多资源

Objective: This Study examines the prevalence of various cardiometabolic risk (CMR) factors that may contribute to metabolic syndrome in a primary care setting. These risk factors were accessed with use of a national electronic health record database. Methods: In the database, from January 1, 2003 to December 3 1, 2004, patients aged 18 to 64 years with information regarding CMR factors were identified by clinical (biometrics), diagnosis (TCD-9 codes) or treatment (prescriptions) information. Results: The study population consisted of 475,651 patients with information on indicators of CMR, excluding patients with bariatric Surgery or a body mass index (BMI) >= 35 kg/m(2). Of these, 72,593 (!5.3%) and 55,928 (11.8%) had metabolic syndrome according to the National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) criteria, respectively. In addition, 162,521 (34.2%) had BMI (>= 27 kg/m(2)) as a risk factor. High blood pressure was identified as a risk factor in 266,371 patients (56.0%). High triglycerides were identified as a risk factor in 10.7%) of the population, low high-density lipoprotein in 16.0%), impaired-fasting glucose in 8.8%, diabetes in 7.2%, and metabolic syndrome (diagnosis) in 0.1%. A total of 178,055 (37.4%) of the study population) subjects had positive indicators of CMR as defined by the NCEP and IDE, Results indicated that obesity is the most prevalent CMR factor representing 90.6% of this at-risk population. Conclusions: The distribution of CMR factors in a primary care database is similar to that established by prospective national health surveys. A key source of identification of risk factors are clinical outcomes including BMI and lab values. Future studies on metabolic syndrome need to link clinically based information with more readily available treatment and diagnosis information.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据